Journal of Diabetes Research
Scope & Guideline
Exploring breakthroughs in diabetes science.
Introduction
Aims and Scopes
- Diabetes Pathophysiology and Mechanisms:
Research exploring the underlying biological mechanisms of diabetes, including insulin resistance, beta-cell dysfunction, and genetic factors influencing disease progression. - Clinical Management and Treatment Strategies:
Studies evaluating various treatment modalities for diabetes, including pharmacological interventions, lifestyle modifications, and emerging therapies such as GLP-1 receptor agonists and SGLT-2 inhibitors. - Diabetes Complications:
Research focused on the complications associated with diabetes, such as cardiovascular disease, diabetic retinopathy, nephropathy, and neuropathy, and their management. - Public Health and Epidemiology:
Investigations into the epidemiology of diabetes, including prevalence, risk factors, and the impact of diabetes on public health, particularly in diverse populations. - Innovative Technologies in Diabetes Management:
Studies that assess the application of new technologies, such as continuous glucose monitoring and telemedicine, in improving diabetes care and patient outcomes. - Nutritional and Lifestyle Interventions:
Research examining the role of diet, physical activity, and behavioral interventions in diabetes prevention and management. - Integrative and Traditional Medicine Approaches:
Exploration of complementary and alternative medicine approaches, including traditional Chinese medicine, in the treatment of diabetes.
Trending and Emerging
- Diabetes and COVID-19 Interactions:
Research examining the relationship between diabetes and COVID-19, including the impact of diabetes on disease severity and outcomes, has gained significant traction in response to the pandemic. - Precision Medicine and Genomics:
Studies focusing on the genetic and genomic aspects of diabetes, including personalized medicine approaches that tailor treatment based on individual genetic profiles, are increasingly prevalent. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting diabetes outcomes, optimizing treatment regimens, and enhancing patient monitoring is an emerging area of focus, reflecting the integration of technology in healthcare. - Behavioral Health and Diabetes Distress:
There is a growing emphasis on the psychological aspects of diabetes management, including diabetes distress and the impact of mental health on treatment adherence and outcomes. - Microbiome and Diabetes:
Research exploring the gut microbiome's role in diabetes pathogenesis and management is on the rise, highlighting the importance of microbiota in metabolic health. - Telemedicine and Remote Patient Monitoring:
The advancement and implementation of telehealth solutions for diabetes management have gained momentum, especially post-pandemic, emphasizing the need for accessible healthcare solutions.
Declining or Waning
- Basic Science Research:
There has been a noticeable decrease in basic science studies that solely focus on cellular and molecular mechanisms of diabetes without direct clinical implications. This shift may be due to an increasing emphasis on translational research that bridges laboratory findings with clinical applications. - Historical Epidemiological Studies:
Research that reviews historical data or trends in diabetes prevalence and outcomes appears to be waning. This could be attributed to a shift towards more contemporary, real-time data analysis and the need for immediate applicability in clinical settings. - Pharmacotherapy Comparisons:
Comparative studies of older diabetes medications are becoming less frequent as newer agents and combination therapies gain prominence in diabetes management discussions. - Conventional Dietary Interventions:
Studies focusing solely on traditional dietary interventions without incorporating modern nutritional science or technology are becoming less common, as there's a trend towards personalized nutrition and integrative approaches.
Similar Journals
Practical Diabetes
Fostering collaboration and discovery in diabetes care.Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.
Journal of Diabetes
Advancing diabetes research for a healthier tomorrow.The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.
Diabetes Therapy
Driving excellence in diabetes care through peer-reviewed studies.Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.
Cardiovascular Diabetology
Advancing the Frontiers of Cardiovascular and Diabetes ResearchCardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.
DIABETES CARE
Connecting research and practice in diabetes care.DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.
Diabetes & Metabolism Journal
Empowering research for a healthier tomorrow.Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.
DIABETOLOGIA
Leading the charge in endocrinology and diabetes insights.DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.
CURRENT DIABETES REVIEWS
Fostering Collaboration in Diabetes ResearchCURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.
Current Diabetes Reports
Elevating the standard of care in diabetes and endocrinology.Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.
BMJ Open Diabetes Research & Care
Transforming diabetes management with peer-reviewed insights.BMJ Open Diabetes Research & Care is a premier open access journal published by the BMJ PUBLISHING GROUP, dedicated to advancing the field of diabetes research and care. With an impressive impact factor and positioned in the Q1 category of Endocrinology, Diabetes and Metabolism, this journal serves as a vital resource for researchers, clinicians, and healthcare professionals striving to improve diabetes management and treatment strategies. Since its inception in 2014, the journal has provided an accessible platform for high-quality, peer-reviewed research, ensuring global outreach and dissemination of groundbreaking findings in diabetes care. With Scopus ranking it at #35 out of 244 in its field, reflecting an 85th percentile ranking, BMJ Open Diabetes Research & Care remains committed to fostering innovation and discourse within the diabetes community. This journal not only publishes original research articles but also invites systematic reviews, clinical studies, and comprehensive reviews, aiming to address the pressing challenges faced in diabetes care today.